Author`s Reply: Should systemic thrombolytic therapy be considered a first-line treatment in acute pulmonary embolism?

We thank the authors for the interest they have shown in our article entitled “Successful treatment of a pulmonary embolism with low-dose prolonged infusion of tissue-type plasminogen activator in a 37-year-old female in the early postoperative period,” published in Anatolian J Cardiol 2014; 14: 400-2. (1).